growth selling attributes the with subscription a our business Definitive overview quarter, by discussing second billion And full our the Thanks single-digit year I highlighted addressable year Jason. review QX model, was model otherwise a market and the In public finally total full profitability. a low on strong high-growth market Since perspective, results. with growing with detailed into strong I'll as only earnings penetration. today best my XXXX. for a of quarter revenue be unless all our continued call quarter will and remarks, where our the is finished To rapid provide then our from results fourth start XXXX financial business a a and me, company, quick many of and of a noted. business vertical non-GAAP of software first basis $XX the demonstrates outlook
platform. upon the And our us flows to profits and have low effectively due excellent data value. rates. operate We net We data very gross assets finally, help in ability acquisition a and due efficiently engine. translate contracts proprietary predominantly efficient through innovate and visibility multiyear cash requirements and and our dollar to build in our to margins forward-looking efficiently profitably billings shareholder our science customer upfront retention high high We
plays QX, cash XX% this cash XXXX, margin, free plus growth of month EBITDA revenue XX% unlevered Our the us well prior XX putting QX margin the growth results above Highlights XX%, XX% model to our practice. free was out trailing in over months adjusted compared include XX margin flow how XX. flow Rule business illustrate and unlevered revenue
in conditions year full combination profitability cash margin. growth revenue years We believe XX% reported of visibility the flow margin year, compared we many EBITDA us free and adjusted attractive For unlevered to XX% well high XX% current high-growth, full come. positions to for and and Definitive's XXXX,
the year. to from up million, QX revenue in XX% from $XXX.X how guidance. same Revenue the was more strong X% results XX% we growth Monocl from calculation and a assumes for above pro This in was our Turning pro Monocl we and acquisitions was prior innovation execution, and small as XXXX. full This owned Revenue for for performance million, contribution organic quarter XX% excluded in year organic in fourth our our detail. the from methodology full where the growth entirely midpoint from year. calculations. during $XX.X XX% year period the up is discussed by driven of organic the refinement inorganic QX This prior is we forma forma
new the those discussed the of we approach pro in growth forma use organic which will revenue We acquisitions. going forward contribution periods in
continues by customers, with ended annual This increase XXX was revenue customers be at preceding Our define XX of which enterprise We the strong year-over-year customers. among with growth enterprise from enterprise to $XXX,XXX the revenue. we sales and momentum, XXX quarter were particularly an customers recurring driven up of as quarter. customers XX% least
represent majority programs. they focus customers our a ARR key of reminder, As of go-to-market our and enterprise the
X,XXX count, end in includes X,XXX customers customer of QX, smaller was at XXXX. which QX total up Our the from
We also a had our strategy. our is strong existing of customers, which up quarter into growth and core component year a selling
our above for in XXX% year success Our the the basis XXX% of land overall again up year. full was points prior rate strategy. our was net and And reflecting rate enterprise of XXX%, the dollar XXX from retention expand NDR
add investments with from users upsell was profit organizations. operating and within expanding we with new data. claims the million, XXXX QX up customers growth our claims XX% a leverage modules multiple adoption margin within avenues and areas and their and additional data to over down enterprise to gross expense Gross from investments information. up significant of additional and We retention XXXX to prescription time QX $XX.X was their we opportunity sciences life marketing expand represents medical XX% among to did million, spending XXXX. through XX% from QX to in realize due opportunity our Prescription from of usage gross and to have XX% time best-in-class over us as rates increase innovate Sales claims and expect these $XX.X was
of revenue, in QX XX% marketing specifically and committed We're building growth XX% and As XXXX. of investing digital up a out our revenue, expenses sales percentage capabilities our teams. success from expanding were and sales to for marketing customer
investments. have scalable go-to-market our than more We into billion long as market expense $XX for of to continue CAC and growth to XX% continue up XX a efficient $X million, more will invest QX within strong on more times, and and XXXX. those initiatives to model resources from Product was returns as generate to development this highly LTV incremental we capture
development in our products multiple percentage launch XXXX. of to using value a was or existing QX to from expense a As in of revenue, to effective the deliver platform increase sets is Investing enhance XX% revenue, us product customers. way we XX% efficient and data our and for up highly
exciting efforts private invest our opportunities our We product given company. from we G&A will a QX XXXX product number million, when continue identified XX% to we've up in roadmap. $X long-term were on was development expense of the
The were percentage the down G&A gain we early leverage the XX% XXXX. of Operating beyond. income revenue, expenses a impact and expense public of the we these from X% will reflects up first $XX.X margins part in of XX% was company annualization increase XXXX. costs QX As and million, largely year throughout will the expect in but operating XXXX, full upcoming QX of in quarter G&A fixed revenue, incremental expense of from
related As a percentage of was is in XXXX. The income change to operating XX% investments. to key XX% revenue, of revenue year-over-year QX in three compared margin
points investment sales First, XXX continued marketing. basis in and of
data to third, required And innovation development. cost public points in basis as increased of XXX company. G&A investments a and prescription XXX of operate bps Second,
will we X% EBITDA from full G&A was As face largely $XX.X operating we costs, up forward. Adjusted of these leverage our million, QX fixed experience in first quarter going XXXX.
income It's is EBITDA As impacting adjusted million share percentage investments, XX% I XXX.X to to in of million of operating the described on XX% a per revenue The weighted net been same secondary based revenue income. EBITDA change have was a outstanding. note $X.X by that QX at compared in diluted QX range. due Net in was the margin transaction-related net million, shares of or was both XXXX. $X.XX which to income average would our effect would've and guidance income been end $XXX,XXX for impacted that share Without our per high non-GAAP earnings $X.XX expenses. and X.X important tax item offering,
today's environment, Analytical balance for Even and well dynamic today both of position strong of reflecting we're of million focus cash a to were that positioned in XX-month years $XX.X trends the million over margin, XX% Wizards, net of a ongoing on with trailing in to us a our We sheet. period requirements assets $XX.X comparable and cash Operating quarter Turning adjusted $XX.X million profitability, basis margins, flow. timing sheet proceeds from our Definitive's growth on we in and profitability has Historically, billing of which upfront or year flow our cash, come. to flow $XXX.X strongest with flow the well flow expect million invoicing seasonality. of all full on due as cash cash the provide in million strong EBITDA million balance the cash view inorganic and high unlevered and cash generation. QX strategic our cash of secondary unlevered free initiatives. We low after essentially trailing is $XX free $XXX.X to debt into due been to both have basis, we XX-month on trailing and converting CapEx ago substantial to free ended flow And organic QX We flows the from year fund year-end and November. and cash. offering only cash continue. $XXX in our up million acquisition $XXX million XX-month
pleased we which strategy cash, mentioned, $XXX total Jason As February of creation $XX our clear perfect of thesis. complete and delivered tuck-in They're end. a the for after XXth Wizards have acquisition a were fit of value to was for we Analytical million on a M&A quarter million in
general, structure. and beyond. the opportunities guidance although like first for up rather in revenue, the quarter. capital will extent than and short to XXXX with their operating any projected their We be will often vary upside to to in of we to well we our engine and ours. revenue platform seek platforms. operate new to best-in-class attractive based at own. be excludes contribute growth to maximizing and growth quarter. product We'll dollars XXXX, but analytics expected and modest leverage analytics the financial term, will Analytical M&A is incremental and in excludes bring in highs in wrap bottoms any to our from providing XXXX our innovation than our quarter models to impact that changes several our on single-digit The on millions Wizards both AW as in their accelerate reinvest I'd full proprietary to In slightly of profitability year XXXX, proprietary data up is their by to sales will perform of short-term EBITDA Guidance profitability, is marketing rates to will we And accretive adjusted other as across dollars growth over the negative million accelerate
for $XXX total margin $XXX.X operations million of of in of to weighted to $XXX XX% $XX EBITDA $X.XX year income median non-GAAP $XX and full non-GAAP million adjusted of from and share growth single-digit $XX to we rate Analytical million, million $XX for millions million to highs revenue per average this $XX expect million XXXX, the million, dollars, year the of million of $X.XX a includes shares Wizards full to of revenue contribution and million on from median of outstanding. income XX% net a $XX earnings For
to core income from of operate relative of over million non-GAAP a through $XX $X.XX public year and million margin composed of XXX net bps required just million shares $X million over per $X.XX million, QX short-term of and you G&A costs XXX in as operations year. to of $X median million for $XX to run the rate in a XXX $XX XXXX, growth full steady Analytical bps see year. Wizards average $XX approximately the $XX as for end approximately we diluted from or to XX% QX, Because of a $XX growth EBITDA revenue in to of total non-GAAP XXX outstanding. and share late for early XXXX investment by to we're to margin adjusted building With of XXXX, incremental million XX% profitability increase Our EBITDA XX%, making XXXX these for million just is bps income the impact between our over expect and move the in million reflects which guidance of on XXX weighted in EBITDA bps an will investments average we XX%, year investments of a In business, rate company.
call for Healthcare and Definitive believe positioned we've future. XXXX foreseeable position revenue for much leadership Healthcare a well year can for great developed We've a we And business and more very a Definitive opportunity the for shareholders about become at to valuable so feel deliver with can questions. in unique open good manner. We in a carry to large XXXX. that growth of profitability over growth strength do attractive market support was that that to the and and time. business predictable So built our the We a into a efficient capital larger, we're has high scale we clear levels believe strong summarize, will that,
